Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|March 5, 2019
Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid TumorsChristopher DeRenzo, Stephen Gottschalk
Advances in Experimental Medicine and Biology|June 14, 2014
Genetically modified T-cell therapy for osteosarcomaChristopher DeRenzo, Stephen Gottschalk
Advances in Experimental Medicine and Biology|June 3, 2020
Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020sChristopher DeRenzo, Stephen Gottschalk
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid TumorsChristopher DeRenzo, Giedre Krenciute, Stephen Gottschalk
EJC Paediatric Oncology|July 3, 2024
CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectivesRebecca Epperly, Stephen Gottschalk, Christopher DeRenzo
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2020
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Frontiers in Oncology|January 16, 2014
Genetically modified T cells to target glioblastomaSimone Krebs, Tania G Rodríguez-Cruz, Christopher Derenzo, et al.
Pediatric Blood & Cancer|October 16, 2018
Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinomaChristopher DeRenzo, Catherine Lam, Carlos Rodriguez-Galindo, et al.
Journal for Immunotherapy of Cancer|March 14, 2023
CD47 expression is critical for CAR T-cell survival in vivoAlex N Beckett, Peter Chockley, Shondra M Pruett-Miller, et al.
Frontiers in Immunology|July 2, 2021
A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T CellsLindsay Jones Talbot, Ashley Chabot, Amy Funk, et al.
Pageof 21